Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1

Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1

Background. This retrospective study aimed to assess the efficacy and toxicities of second-line chemotherapy with irinotecan, leucovorin, and 5-fluorouracil (5-FU) in metastatic gastric cancer (MGC) patients previously treated with docetaxel and S-1 with or without oxaliplatin (DS/DOS). Patients an...

Full description

Bibliographic Details
Main Authors: Jung, Joo Young, Ryu, Min-Hee, Ryoo, Baek-Yeol, Han, Boram, Cho, Ji Woong, Lim, Man Sup, Lim, Hyun, Kang, Ho Suk, Kim, Min-Jeong, Ha, Hong Il, Song, Hunho, Kim, Jung Han, Kim, Hyeong Su, Kang, Yoon-Koo, Zang, Dae Young
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709667/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709667/

Similar Items